20972 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-9
COMBINED DELIVERY OF ANTIGENS AND TOLEROGENIC SIGNALS VIA DUAL-SIZED HYDROGEL SPHERES AND MOF COMPOSITES FOR TYPE-1 DIABETES VACCINE DEVELOPMENT
#2METHODS AND COMPOSITIONS TO MODULATE RIOK2
#3MODULATING GAMMA-C-CYTOKINE ACTIVITY
#4CELL CULTURE FOR TREATING DISEASE IN THE LOWER LIMBS
#5FORMULATION AND TREATMENT FOR OPHTHALMIC DISORDERS
#6T CELL RECEPTORS AND METHODS OF USE THEREOF
#7Compositions for biological systems and methods for preparing and using the same
#8Interleukin Combination and Use Thereof
#9Modulating gamma-c-cytokine activity
#10Compositions for biological systems and methods for preparing and using the same
#11Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors
#12Embryo implantation
#13Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors
#14CONJUGATES OF GM-CSF AND IL-9, COMPOSITIONS AND METHODS RELATED THERETO
#15Use of Th9 cells and IL-9 for the treatment of melanoma
#16EXTRACELLULAR TNF INHIBITORS FOR TREATING CNS DISORDERS
#17Porous objects having immobilized encapsulated biomolecules
#18Methods and compositions for treating and preventing inflammatory conditions
#19Techniques to treat neurological disorders by enhancing the presence of anti-inflammatory mediators
#20Extracellular TNF inhibitors for treating CNS disorders
#21Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators